Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease.
Bartl S, Oueslati A, Southwell AL, Siddu A, Parth M, David LS, Maxan A, Salhat N, Burkert M, Mairhofer A, Friedrich T, Pankevych H, Balazs K, Staffler G, Hayden MR, Cicchetti F, Smrzka OW.
Bartl S, et al. Among authors: smrzka ow.
Neurobiol Dis. 2020 Jul;141:104943. doi: 10.1016/j.nbd.2020.104943. Epub 2020 May 12.
Neurobiol Dis. 2020.
PMID: 32407769
Free article.